VolitionRx Ltd

Revolutionizing

Cancer Diagnosis

Volition's goal is to make its non-invasive cancer blood tests as common and simple to use as existing diabetic and cholesterol tests on similar formats.

About Volition Watch Video

Technology

VolitionRx is developing a range of diagnostic tests for cancer and other conditions. Each test is based on the Nucleosomics® technology: measurement and identification of nucleosomes in the blood. Learn More About Our Technology ›

Colorectal Cancer

VolitionRx is currently assessing the efficacy of NuQ® for the diagnosis of colorectal cancers, in a number of clinical trials in Europe. Learn More About Colorectal Cancers ›

Upcoming Events

BioWin Day 2014

Louvain-la-Neuve, Belgium

View Events Calendar ›

Stock Data View Investor Relations ›

OTCQB VNRX
Change
Volume
Market Cap
Sign Up Today

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse the site, you will accept our use of cookies.